TNF and glioblastoma: As SMCs induce inflammatory cell death in cells producing [41] or exposed to TNF-α (Fig. 1B) and themselves have broad immunostimulatory effects [20, 42, 43], combinations with immunotherapies such as oncolytic viruses [44] and immune checkpoint blockade in GBM [37] have produced potent synergistic effects.